dihexa hgf/c-met agonist

dihexa hgf/c-met agonist HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte growth factor (HGF) binding

Name: dihexa hgf/c-met agonist HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Hepatocyte growth factor (HGF) binding
Brand: equiscorp.hu
SKU: 84833701138
Price: 29.74 USD
Availability: InStock
Rating: 4.054 (8 reviews)

Hepatocyte growth factor (HGF) binding c Met activates signaling Download Scientific Diagram Molecular mechanism(s) of regulation(s) of c MET HGF signaling in head and neck cancer Molecular Cancer Springer Nature Link Role of the HGF c MET tyrosine kinase inhibitors in metastasic melanoma Molecular Cancer Springer Nature Link dihexa hgf c met agonist Growth factors and their peptide mimetics for treatment of traumatic brain

SKU: 84833701138 · From equiscorp.hu

4.1

USD29.74 USD56.74

Pay in 4 interest-free payments of $7.43 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Athira Pharma's fosgonimeton (ATH-1017), part of the same HGF/c-Met program, failed the primary endpoint of its Phase 2/3 LIFT-AD Alzheimer's trial in September 2024